Establishment Labs Holdings Inc
Gesloten
SectorGezondheidszorg
70.42 -1.25
Overzicht
Wijziging aandelenprijs
24u
Min
70.79
Max
74.45
Inkomsten | 1.6M -12M |
|---|---|
Verkoop | 7.7M 68M |
EPS | -0.39 |
Winstmarge | -17.394 |
Werknemers | 1,004 |
EBITDA | 4M 652K |
Volgende Winsten | 4 nov 2026 |
|---|
Marktkapitalisatie | -517M 2.2B |
|---|---|
Vorige openingsprijs | 71.67 |
Vorige sluitingsprijs | 70.42 |
Establishment Labs Holdings Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
Establishment Labs Holdings Inc Prognose
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.